Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors
NCT07236840 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2026-02-24
Summary
The goal of this observational study is to evaluate the feasibility and accuracy of a self-administered remote neurological examination using the "Iskhaa" mobile application in patients with brain tumors aged above 5 years who are able to follow app-based instructions.
The main questions it aims to answer are:
1. Development of a mobile application equipped with symptom assessment and recording videos as patients perform specific neurological tasks.
2. Development and validation of the AI model to detect functional changes and predict subsequent neurological deterioration.
Participants will:
1. Use the Iskhaa mobile application to perform guided self-neurological examinations following pre-recorded video instructions.
2. Complete EORTC QLQ-C30 and BN20 questionnaires for quality of life assessment.
3. Record and upload videos (e.g., speech, walking, limb movements) using their mobile camera for analysis.
4. In Phase 1 (onsite), 100 participants will use the app under supervision to ensure usability and accuracy.
5. In Phase 2 (offsite), 500 participants will use the app independently at home for monthly self-assessments, with reminders and follow-up support.
6. Continue routine clinic visits every 3-6 months and imaging every 6-12 months as per standard clinical care.
The study will compare app-recorded data with physician assessments to determine agreement and validity of remote neurological monitoring using artificial intelligence analysis.
Conditions
- CNS Tumor
- Artificial Intelligence (AI)
- Glioma
- Digital Health
Interventions
- BEHAVIORAL
-
Neurological assessment
This assessment will include Speech, Cerebellar function and Quality of Life questionnaires using mobile application.
Sponsors & Collaborators
-
Bhabha Atomic Research Centre (BARC), Mumbai
collaborator UNKNOWN -
Tata Memorial Centre
lead OTHER
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-20
- Primary Completion
- 2027-11-01
- Completion
- 2027-11-05
Countries
- India
Study Locations
More Related Trials
-
Cognitive Function After Radiation Therapy for Brain Tumours
NCT04118426 ·Status: COMPLETED
-
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma
NCT02023346 ·Status: COMPLETED
-
Cerebral Morbidity After Radiation Therapy for Brain Tumors
NCT04292353 ·Status: UNKNOWN
-
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
NCT06779487 ·Status: RECRUITING
-
Re-irradiation of High Grade Gliomas: a Quality of Life Study
NCT01711580 ·Status: WITHDRAWN
-
Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:
NCT06036706 ·Status: RECRUITING ·Phase: NA
-
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
NCT01417507 ·Status: COMPLETED
-
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
NCT03534050 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Artificial Intelligence Neuropathologist
NCT05300113 ·Status: UNKNOWN
-
Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas
NCT06454097 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology
NCT04671368 ·Status: UNKNOWN ·Phase: NA
-
Measuring and Mapping Cognitive Decline After Brain Radiosurgery
NCT06466720 ·Status: ACTIVE_NOT_RECRUITING
-
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
NCT00147056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Protocol for Evaluating a Planning Algorithm for Gamma Knife Radiosurgery
NCT03520829 ·Status: UNKNOWN
-
Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging
NCT04313140 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Glioma Characterization Through Molecular Imaging
NCT03684109 ·Status: RECRUITING ·Phase: NA
-
Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis
NCT04220424 ·Status: UNKNOWN
-
Indocyanine Green for Central Nervous System Tumors
NCT02710240 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Response Assessment During MR-guided Radiation Therapy for Glioblastoma
NCT05565326 ·Status: RECRUITING
-
Combing a Deep Learning-Based Radiomics With Liquid Biopsy for Preoperative and Non-invasive Diagnosis of Glioma
NCT05536024 ·Status: UNKNOWN
-
Efficacy of a Mixed Distancial Neuropsychological Rehabilitation Program in Patients With Grade 2 or 3 Diffuse Glioma
NCT06468176 ·Status: RECRUITING ·Phase: NA
-
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
NCT05504681 ·Status: RECRUITING
-
MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence
NCT04215211 ·Status: RECRUITING
-
Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study
NCT02941302 ·Status: UNKNOWN ·Phase: NA
-
Cavity Boost Radiation Therapy vs. Observation in Cerebral Metastases After Complete Surgical Resection
NCT02887651 ·Status: UNKNOWN ·Phase: NA